Literature DB >> 8890223

Association of RTX toxins with erythrocytes.

M E Bauer1, R A Welch.   

Abstract

A critical step in the target cell attack by RTX cytotoxins is their association with target cells. A binding assay was used to study the association of the Escherichia coli hemolysin protein (HlyA) with erythrocytes. Several parameters required for lysis by HlyA were tested for their effects on its initial association with erythrocytes. The results demonstrate that HlyA binding to target cells is independent of several structural components of the active toxin, including the N-terminal hydrophobic region, the glycine-rich repeat region, and the HlyC-dependent acylation of HlyA. Further, the association with erythrocytes was independent of Ca2+ concentration or temperature, while the lytic event is both Ca2+ dependent and temperature dependent. The association of two other RTX toxin proteins, the Pasteurella haemolytica leukotoxin (LktA) and the enterohemorrhagic E. coli toxin (EhxA), were also examined; these toxins bound to erythrocytes much less efficiently than did HlyA. The association of HlyA with erythrocytes occurred rapidly, within 12 s of incubation, and demonstrated no measurable dissociation. HlyA bound to erythrocytes with a maximum of approximately 2,000 molecules per cell. Competition between active HlyA and unacylated HlyA demonstrated no inhibition of binding by unacylated HlyA; rather, active HlyA appeared to displace unacylated HlyA on the cell surface. These data demonstrate that binding and lysis by HlyA are separable events and challenge the concept of nonspecific binding to the cell surface by RTX toxins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890223      PMCID: PMC174429          DOI: 10.1128/iai.64.11.4665-4672.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Deletion analysis resolves cell-binding and lytic domains of the Pasteurella leukotoxin.

Authors:  W T Cruz; R Young; Y F Chang; D K Struck
Journal:  Mol Microbiol       Date:  1990-11       Impact factor: 3.501

2.  Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation.

Authors:  J P Issartel; V Koronakis; C Hughes
Journal:  Nature       Date:  1991-06-27       Impact factor: 49.962

3.  Characterization of monoclonal antibodies against the Escherichia coli hemolysin.

Authors:  S Pellett; D F Boehm; I S Snyder; G Rowe; R A Welch
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  Identification of RTX toxin target cell specificity domains by use of hybrid genes.

Authors:  C Forestier; R A Welch
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Domains of Escherichia coli hemolysin (HlyA) involved in binding of calcium and erythrocyte membranes.

Authors:  D F Boehm; R A Welch; I S Snyder
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Subhemolytic doses of Escherichia coli hemolysin evoke large quantities of lipoxygenase products in human neutrophils.

Authors:  F Grimminger; C Scholz; S Bhakdi; W Seeger
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

7.  Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils.

Authors:  F Grimminger; U Sibelius; S Bhakdi; N Suttorp; W Seeger
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Analysis of the haemolysin transport process through the secretion from Escherichia coli of PCM, CAT or beta-galactosidase fused to the Hly C-terminal signal domain.

Authors:  B Kenny; R Haigh; I B Holland
Journal:  Mol Microbiol       Date:  1991-10       Impact factor: 3.501

9.  Influence of calcium on secretion and activity of the cytolysins of Actinobacillus pleuropneumoniae.

Authors:  L A van Leengoed; H W Dickerson
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

10.  Synthesis, inactivation, and localization of extracellular and intracellular Escherichia coli hemolysins.

Authors:  R L Oropeza-Wekerle; E Müller; P Kern; R Meyermann; W Goebel
Journal:  J Bacteriol       Date:  1989-05       Impact factor: 3.490

View more
  22 in total

1.  Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles.

Authors:  C Hyland; L Vuillard; C Hughes; V Koronakis
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

2.  Characterization of binding of adenylate cyclase toxin to target cells by flow cytometry.

Authors:  M C Gray; W Ross; K Kim; E L Hewlett
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Prelytic and lytic conformations of erythrocyte-associated Escherichia coli hemolysin.

Authors:  M Moayeri; R A Welch
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

4.  The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways.

Authors:  Bijaya K Dhakal; Matthew A Mulvey
Journal:  Cell Host Microbe       Date:  2012-01-19       Impact factor: 21.023

5.  Regulation of Aggregatibacter (Actinobacillus) actinomycetemcomitans leukotoxin secretion by iron.

Authors:  Nataliya V Balashova; Roger Diaz; Sergey V Balashov; Juan A Crosby; Scott C Kachlany
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

6.  Pore forming activity of the potent RTX-toxin produced by pediatric pathogen Kingella kingae: Characterization and comparison to other RTX-family members.

Authors:  Iván Bárcena-Uribarri; Roland Benz; Mathias Winterhalter; Eleonora Zakharian; Nataliya Balashova
Journal:  Biochim Biophys Acta       Date:  2015-04-07

7.  Cloning and characterization of two bistructural S-layer-RTX proteins from Campylobacter rectus.

Authors:  M Braun; P Kuhnert; J Nicolet; A P Burnens; J Frey
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

8.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 9.  Acylation of Escherichia coli hemolysin: a unique protein lipidation mechanism underlying toxin function.

Authors:  P Stanley; V Koronakis; C Hughes
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

10.  Use of zebrafish to probe the divergent virulence potentials and toxin requirements of extraintestinal pathogenic Escherichia coli.

Authors:  Travis J Wiles; Jean M Bower; Michael J Redd; Matthew A Mulvey
Journal:  PLoS Pathog       Date:  2009-12-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.